Healthcare Triangle Reports Financial Obligations & Officer Changes
Ticker: HCTI · Form: 8-K · Filed: Sep 10, 2024 · CIK: 1839285
| Field | Detail |
|---|---|
| Company | Healthcare Triangle, Inc. (HCTI) |
| Form Type | 8-K |
| Filed Date | Sep 10, 2024 |
| Risk Level | medium |
| Pages | 2 |
| Reading Time | 3 min |
| Key Dollar Amounts | $0.00001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-governance, financial-obligation, officer-departure, director-election
Related Tickers: HTRI
TL;DR
HTRI filed an 8-K: financial obligations triggered, directors/officers changed. Watch for impacts.
AI Summary
Healthcare Triangle, Inc. filed an 8-K on September 10, 2024, reporting on two key events. Firstly, it disclosed triggering events that accelerate or increase a direct financial obligation or an obligation under an off-balance sheet arrangement. Secondly, the company reported on the departure of directors or certain officers, the election of directors, the appointment of certain officers, and compensatory arrangements for certain officers. The filing date indicates these events occurred or were reported as of September 4, 2024.
Why It Matters
This filing signals potential changes in the company's financial obligations and its leadership structure, which could impact its operational and financial trajectory.
Risk Assessment
Risk Level: medium — The filing addresses both financial obligations and changes in corporate governance, which can introduce uncertainty and potential risks.
Key Players & Entities
- Healthcare Triangle, Inc. (company) — Registrant
- September 4, 2024 (date) — Earliest event reported date
- September 10, 2024 (date) — Filing date
FAQ
What specific financial obligations are being accelerated or increased for Healthcare Triangle, Inc.?
The filing indicates triggering events related to financial obligations but does not specify the exact nature or amount of these obligations in the provided text.
Which directors or officers have departed from Healthcare Triangle, Inc.?
The filing states that there were departures of directors or certain officers, but the specific names of those individuals are not detailed in the provided excerpt.
Were new directors elected or officers appointed at Healthcare Triangle, Inc.?
Yes, the filing mentions the election of directors and the appointment of certain officers as part of the reported events.
What is the primary business of Healthcare Triangle, Inc.?
Healthcare Triangle, Inc. is classified under SERVICES-COMPUTER INTEGRATED SYSTEMS DESIGN [7373].
What is the principal executive office address for Healthcare Triangle, Inc.?
The principal executive offices are located at 7901 Stoneridge Dr., Suite 220, Pleasanton, CA 94588.
Filing Stats: 702 words · 3 min read · ~2 pages · Grade level 14.5 · Accepted 2024-09-10 17:00:10
Key Financial Figures
- $0.00001 — ch registered Common Stock, par value $0.00001 per share HCTI The Nasdaq Stock Mar
Filing Documents
- ea0214159-8k_healthcare.htm (8-K) — 25KB
- 0001213900-24-077409.txt ( ) — 197KB
- hcti-20240904.xsd (EX-101.SCH) — 3KB
- hcti-20240904_lab.xml (EX-101.LAB) — 33KB
- hcti-20240904_pre.xml (EX-101.PRE) — 22KB
- ea0214159-8k_healthcare_htm.xml (XML) — 4KB
04 Triggering Events That Accelerate
Item 2.04 Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement. On September 4, 2024, Healthcare Triangle, Inc. ("HCTI" or the "Company") received a notice of default from Seacoast Business Funding, a division of Seacoast National Bank ("Seacoast") with respect to the Purchasing Agreement by and between the Company and Seacoast dated May 2, 2022 ("Purchasing Agreement"). As a result of the Event of Default, Seacoast is legally entitled to, among other things, (i) declare all of the obligations under the Purchasing Agreement to be immediately due, payable and performable, and to enforce collection of the obligations by repossessing and disposing of any interest in the collateral, and to proceed against the Company for any deficiency, and (ii) pursue and enforce any and all of its remedies against the Company as are otherwise more specifically set forth in the Purchasing Agreement or as is otherwise permitted under applicable law. As of the date of this Current Report on Form 8-K, no action has been taken by Seacoast to accelerate the Company's obligations, to foreclose on the loan collateral or to enforce its rights under the terms of the Purchasing Agreement. The Company is attempting to resolve this matter with Seacoast, and may defend any enforcement action taken by Seacoast. However, the Company cannot guarantee a resolution on a timely basis, on favorable terms, or at all. If the Company is unable to resolve the alleged defaults under the Purchasing Agreement, it would have a material adverse effect on the Company's liquidity, financial condition and results of operations, and could cause the Company to become bankrupt or insolvent. Item5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers Departure of Interim Chief Executive Officer On September 4, 2024, Anand Kumar, the Interim C